Loading...
 
Translate Register Log In Login with facebookLogin and Register

Omega-3 helped Alzheimer’s only if good level of B vitamins – RCT April 2019

Homocysteine Status Modifies the Treatment Effect of Omega-3 Fatty Acids on Cognition in a Randomized Clinical Trial in Mild to Moderate Alzheimer's Disease: The OmegAD Study.

J Alzheimers Dis. 2019 Apr 1. doi: 10.3233/JAD-181148.
Jernerén F1, Cederholm T2,3, Refsum H4,5, Smith AD5, Turner C5, Palmblad J6, Eriksdotter M3,7, Hjorth E7, Faxen-Irving G7, Wahlund LO7, Schultzberg M7, Basun H2, Freund-Levi Y7,8,9,10.

VitaminDWiki


Items in both categories Omega-3 and Cognitive are listed here:


BACKGROUND:
Trials of supplementation with omega-3 fatty acids (ω3-FAs) in patients with mild cognitive impairment or Alzheimer's disease (AD) have given inconsistent effects on cognitive decline. There is evidence of an interaction between B vitamin status and ω3-FAs in relation to brain atrophy and cognitive decline.

OBJECTIVE:
We investigated whether baseline levels of plasma total homocysteine (tHcy), a marker of B vitamin status, modify the effects of ω3-FAs supplementation on cognitive performance in moderate AD.

METHODS:
This post hoc analysis of the OmegAD trial included 171 community-based patients with AD (MMSE≥15): 88 patients received daily doses of 1.7 g docosahexaenoic acid and 0.6 g eicosapentaenoic acid for 6 months. Treatment outcome on cognition was analyzed according to baseline levels of tHcy using a general linear model and ANCOVA.

RESULTS:
We found significant interactions between ω3-FA supplementation and tHcy on cognition and clinical stage assessed by

  • MMSE (p = 0.040), global
  • CDR (p = 0.059), and
  • CDRsob (p = 0.023),

but not on ADAS-cog (p = 0.649). In patients with tHcy levels <11.7μmol/L, ω3-FA supplementation improved cognitive performance as measured by MMSE (+7.1%, 95% CI: 0.59 to 13.7%, p = 0.033) and clinical status as measured by CDRsob (-22.3%, 95% CI: -5.8 to -38.7%, p = 0.009) compared to placebo.

CONCLUSION:
The effect of ω3-FA supplementation on MMSE and CDR appears to be influenced by baseline tHcy, suggesting that adequate B vitamin status is required to obtain beneficial effects of ω3-FA on cognition.

Created by admin. Last Modification: Wednesday April 10, 2019 15:09:58 GMT-0000 by admin. (Version 1)
See any problem with this page? Report it (FINALLY WORKS)